Skip to content

S. 2683 · 118th Congress (2023–2025)

AMERICAN DRUGS Act

This bill generally limits coverage of generic drugs under federal health care programs to those that are manufactured domestically.

Specifically, the bill prohibits coverage of generic drugs that are manufactured in foreign countries under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), TRICARE, and benefits provided by the Veterans' Administration. Coverage is permitted for foreign-made generic drugs if there are fewer than two other generic versions that are manufactured domestically or if the generic versions that are manufactured domestically are in shortage or soon to be discontinued. The Food and Drug Administration (FDA) must notify appropriate agencies about brand-name drugs that have at least two generic versions that are manufactured domestically and those that do not.

The bill also allows the FDA to expedite the development and review of applications for generic versions of brand-name drugs that do not have at least two generic versions that are manufactured domestically.

Show official title

A bill to establish requirements for purchasing certain generic drugs from manufacturers who produce the drug domestically.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 2683’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Rick Scott (R-FL)
Cosponsors
2 cosponsors

0 original · 2 later

  1. Sen. Mike Braun (R-IN)· Later · Sep 5, 2023
  2. Sen. J. D. Vance (R-OH)· Later · Sep 5, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Jul 27, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. AMERICAN DRUGS Act

    Display title, Short title · Introduced in Senate

  2. Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act

    Short title · Introduced in Senate

  3. A bill to establish requirements for purchasing certain generic drugs from manufacturers who produce the drug domestically.

    Official title · Introduced in Senate